BVF PARTNERS L P/IL - Director, Other*, 10%+ Owner at CTI BIOPHARMA CORP

Insider Transactions and Holdings

Entity Type
Company
Role
Director, Other*, 10%+ Owner
Issuer Symbol
CTIC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by BVF PARTNERS L P/IL since 13 Feb 2025

Holdings reported by BVF PARTNERS L P/IL for CTI BIOPHARMA CORP

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.001 0 $9.10 26 Jun 2023 Direct
Common Stock, par value $0.001 0 $9.10 26 Jun 2023 Indirect
Series O Convertible Preferred Stock 0 09 Aug 2022 Direct Common Stock, par value $0.001 682,666
Series O Convertible Preferred Stock 0 09 Aug 2022 Indirect Common Stock, par value $0.001 1,520,000
Series X1 Convertible Preferred Stock 0 26 Jun 2023 Direct Common Stock, par value $0.001 170,000
Series X Convertible Preferred Stock 0 26 Jun 2023 Direct Common Stock, par value $0.001 1,910,000
Series X Convertible Preferred Stock 0 26 Jun 2023 Indirect Common Stock, par value $0.001 120,000
Stock Option (Right to Buy) 0 26 Jun 2023 Indirect Common Stock, par value $0.001 80,000

Transactions reported by BVF PARTNERS L P/IL for CTI BIOPHARMA CORP

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.